Update: business continuity plan for COVID-19 -

Update: business continuity plan for COVID-19

  • Equilibar facility

To our Equilibar customers and partners,

Regarding the ongoing COVID-19 crisis, I would like to assure our customers and other partners that Equilibar has adopted several measures to ensure that we can continue to support you as we move forward.

  1. Our engineers are working and welcome your inquiries. They are ready to answer questions and help you with any fluid control challenge. They are available via email and phone as well as many video conferencing platforms. Please don’t hesitate to contact them.
  2. Our skilled production team is working full time using recommended accommodations to ensure their safety and also to allow us to meet our commitments in a timely manner.
  3. We do not anticipate any supply problems at this time. We have ample stock available in our inventory, and our partner shops have raw material available to last for several months of manufacturing.

As others have noted, now more than ever is the time to collaborate to find innovative solutions to problems the world is facing. Our goal is to use this time not only to support our customers, but also to focus on R&D projects to expand our technology. We are giving special attention to our single-use fluid control valve for Biotech, but we also continue to work on products for fuel cell research, clean energy, and other vital endeavors. We welcome your ideas and challenges.

Jeff Jennings, Equilibar founder

Jeff Jennings, founder

We are thankful for technology that allows us to stay in touch with you. Stay healthy and safe!

Jeff Jennings, President

Equilibar

Categories
Equilibar News
Oblique view of ultra-sensitive back pressure regulator

COVID-19 Update: Equilibar working with ventilator designers to increase access to component parts

Since Friday March 20, 2020, Equilibar has focused on working to modify the design of our fluid control valves to enable them to serve as building blocks for medical ventilator systems.  Our technical team has made rapid progress.  Based on collaboration with bio-engineering and medical experts, we believe we have developed designs that can contribute Read More

Read More